Mozart Therapeutics, Inc

Mozart Therapeutics, Inc., located in Pittsburgh, PA, is a clinical-stage biopharmaceutical company dedicated to developing therapies that restore healthy immune function in patients suffering from autoimmune diseases. The company's innovative approach focuses on first-in-class CD8 Treg modulators that target the root cause of immune dysregulation to achieve durable immune homeostasis across various autoimmune disorders.

Building on the pioneering research of Professor Mark Davis, Mozart Therapeutics is advancing a pipeline of novel biologics aimed at addressing CD8 Treg dysfunction. Through these efforts, the company seeks to mitigate progressive inflammation and tissue damage caused by harmful autoimmune responses.

Generated from the website